Purpose: To report visual, refractive and topographic outcomes after corneal collagen crosslinking (CXL) for progressive keratoconus in paediatric eyes. Methods: In this prospective interventional study, twenty eyes of eighteen patients with progressive keratoconus were included. All eyes underwent CXL with riboflavin after documented progression of the disease. Informed, written consent was taken from the parents of the patients. The patients were followed up for 6 mon- 
Introduction
Keratoconus is a slowly progressive, noninflammatory corneal degenerative disorder characterized by changes in corneal collagen structure and organization [1] - [3] . Decreased mechanical corneal stability plays an important role in the progressive protrusion of the keratoconic cornea, resulting in mild to marked impairment of visual acuity owing to irregular astigmatism, progressive myopia, corneal thinning, and central corneal scarring [4] . The 3-dimensional configuration of the collagen lamella fundamentally codetermines the cornea's resistance. Biochemical and immunohistochemical studies of the matrix's proteoglycans show differences between normal and keratoconic corneas [5] - [8] . Enzymatic alterations with an increased expression proteolytic enzymes, [6] [9]- [11] decreased concentration of protease inhibitors [9] [12] and modified configuration of the stromal collagen lamella [13] have been observed.
Diagnosis of keratoconus in childhood is a negative prognostic factor for progression, increasing the probability of the need for corneal transplantation [14] . Younger patients are particularly at risk for faster progression of the disease [14] [15] . Corneal collagen cross-linking (CXL), stabilizes progressive keratoconus, prevents some of the underlying pathophysiologic mechanisms of the disease, and avoids the need for penetrating keratoplasty [15] . CXL increases the biomechanical strength of the human cornea by about 300% by the combined action of a photosensitizing substance (riboflavin) and ultraviolet (UV) light from a solid-state UVA source [16] . The treatment creates additional chemical bonds inside the anterior 200 -300 microns of the corneal stroma by means of photopolymerization. In this study we examined the refractive and tomographic outcomes of CXL in paediatric patients with progressive keratoconus.
Materials and Methods
Forty one eyes of 34 consecutive patients were included in this prospective, non-randomized comparative study. Diagnosis of keratoconus was based on slit lamp findings and/or corneal images generated by Pentacam rotating Scheimpflug imaging system (Oculus Optikgerate GmbH, Wetzlar, Germany). Patients who had documented progression of keratoconus in the last six months i.e., change in refraction (>1D cylinder, 0.5D spherical), increase in steep keratometry value > 1D, progressive corneal thinning (>5% decrease) and corneal thickness > 400 μm at the thinnest point were included in the study. Exclusion criteria included any patient with history of ophthalmic surgery, corneal scarring or any significant ophthalmic disease other than keratoconus. Patients were divided into two groups; Group 1 included keratoconus patients in paediatric age group i.e. age ≤ 16 yrs (n = 20), whereas Group 2 included keratoconus patients >16 yrs (n = 21). All eyes underwent an extensive ophthalmologic examination that included visual acuity measurements, manifest refraction, slit lamp biomicroscopy, Goldmann tonometry, and fundus examination. The study followed the tenets of the Declaration of Helsinki and was approved by the Institutional review board. Informed consent was obtained from parents of each subject (<18 years of age) or from the patient itself after explanation of the nature of the study.
Surgical Technique
The surgical procedure of corneal cross-linking induced by riboflavin and UVA was performed in all patients according to a modification of the Siena protocol [17] .
The procedure was performed on a day care basis. Pre-operative antibiotic drop (moxifloxacin 0.5%) was instilled 2 hourly one day prior to surgery whereas 2% pilocarpine drops three times 1 hr prior to procedure. Under topical anaesthesia with 0.5% proparacaine and after applying a lid speculum, the cornea was de-epithelised over 8 mm diameter with a blunt spatula. Photosensitizing riboflavin 0.1% + 20% dextran (Ricrolin; Sooft, Montegiorgio, Italy), was applied every 5 minutes for 30 minutes to achieve adequate penetration of the solution. The eye was then irradiated for 30 minutes with UVA of 370 nm wavelength at a working distance of 54 mm with an irradiance of 3 mW/cm 2 using a VEGA X-linker (Costruzione Strumenti Oftalmici, Florence, Italy). Riboflavin solution was applied once every 5 minutes during irradiation. At the end of the procedure, saline wash given to cornea and conjunctiva to remove excess riboflavin and antibiotics drops instilled. A soft bandage contact lens was applied.
Follow up
Patients were seen at the clinic daily until re-epithelization was complete. Postoperatively, topical moxifloxacin 0.5% was prescribed tid for 2 weeks along with a combination of topical tobramycin 0.3% + flurometholone 0.1% tid for 4 weeks. Topical carboxymethylcellulose 0.5% was prescribed qid for 2 -3 months. The therapeutic contact lens was removed on the 4 th postoperative day in most cases. Subsequent examinations were at 1, 3, and 6 months. At each examination, refraction, best corrected visual acuity (BCVA) with glasses, Pentacam Scheimpflug imaging (Oculus Optikgerate GmbH, Wetzlar, Germany), central corneal thickness (CCT), and intraocular pressure (IOP) were recorded.
Statistical Analysis
Statistical analysis was performed with SPSS software version 17. Paired T-test was applied to compare the means within each group. Independent T-test was applied to compare the significant difference between the means of both groups. p ≤ 0.05 was considered significant.
Results
Baseline characteristics of both groups are shown in Table 1 . The mean preoperative cylindrical refractive error and average K values were significantly higher in the younger age group. The M:F ratio was higher in the younger age group.
In both groups the mean decimal BCVA reduced insignificantly ( Figure 1 ) at 1 month follow up and improved thereafter at 3 and 6 months postoperatively. In Group 2 there was a statistically significant improvement in BCVA between 1 month and three months (mean change +0.08; p = 0.008) and between one and 6 months postoperatively (mean change +0.09; p = 0.004). When both groups were compared, the BCVA was significantly better in the Group 2 only at the 3 month follow up (p = 0.042), the difference in BCVA being insignificant at 6 months.
In Group 1, the mean spherical refractive error increased insignificantly from a mean preoperative value of −2.5D to −3.2D at 3 months and −4.4D at 6 months postoperatively. Whereas in Group 2 the mean spherical refractive error reduced insignificantly from −3.4D preoperatively to −3.2D and −2. The thinnest pachymetry (Figure 6 ) reduced significantly in Group 1 from 459.1 μm at baseline to 400.8 μm (p < 0.001), 405.9 μm (p < 0.001) and 413.6 μm (p < 0.001) at one, three and six months respectively. In Group 2 as well the thinnest pachymetry reduced significantly from 477.3 μm at baseline to 429.8 μm (p < 0.0001), 438.6 μm (p < 0.0001), 446.3 μm (p < 0.0001) at one, three and six months respectively.
Discussion
This study compares the short term results of corneal collagen crosslinking with riboflavin for progressive keratoconus between adult and paediatric corneas. In this non-randomized study we analyzed and compared visual acuity, refractive, topographic and pachymetric outcomes in both groups with no procedure related complications.
Both groups showed marginal (insignificant) improvement in BCVA (Figure 1) at six months when compared to baseline. BCVA dropped at the 1 month follow up in both groups which was due to postoperative stromal haze and corneal edema which has been shown to be detectable clinically at one month postoperatively in 70% of patients post crosslinking [17] . In a large longitudinal study by Raiskup-Wolf et al. [18] 53% of 142 eyes showed significant improvement in BCVA in the first year. More recently the "Siena CXL Pediatrics" trial involving 152 patients aged 18 years or younger showed significant improvement in BCVA of +0.15 -+0. 16 Snellen lines at 36 months [19] . In their study, they found that final BCVA was better in the Group which had a corneal thickness > 450 µm at the time of enrollment because of an earlier stage of keratoconus at the time. Our patients had a follow up of 6 months. Perhaps a longer follow up would be needed to show a significant improvement in BCVA.
The mean spherical refractive error (Figure 2 ) and the spherical equivalent (S Eq.) of refraction (Figure 4 ) increased in the younger age group whereas it improved in the older group. The difference in the S Eq. between both groups was significant at 6 months (p = 0.024) postoperatively. We did not measure axial lengths in our patients at any point in the study. Either progression of keratoconus or increasing axial length would explain this myopic shift in the younger age group. The improvement of S Eq. in the older group was 0.9D which is compa- rable to previous studies ( Table 2 ). In Group 1 the mean refractive cylinder reduced significantly at 6 months by 1.16D (p = 0.003). In the older group (Figure 3 ) the mean refractive cylinder worsened in the initial two follow ups and then reduced insignificantly by 0.19D at the 6 month follow up. Caporossi et al. [17] , in their series of 44 patients (age range 10 -40 years) reported initial worsening of mean refractive cylinder in the first three months following crosslinking followed by an insignificant mean reduction by −0.52D at one year. The average K value reduced significantly by 0.34D in Group 1 at 6 months. This decrease, though of a larger magnitude in Group 2 (−1.16D), did not approach statistical significance. The difference between both groups was significant at 6months. It remains unclear why the magnitude of reduction in the younger age group was less as compared to the older group and previous reports ( Table 2 ). In the Siena CXL Pediatrics trial [19] , the average K reduction in the thicker group (patients aged 18 years or younger with preoperative corneal thickness > 450 µm) was statistically significant at 12 months (mean change −0.46D; p = 0.0051).In the same study, the average K reduction in the thinner group (patients with preoperative corneal thickness < 450 µm) was statistically significant at 12 months (mean change −0.45D, p = 0.0048). The pediatric group, in our study showed statistically significant mean change of −0.34D at 6 months (p = 0.015). In both groups there was increase in average K at one month followed by a decrease at 3 and 6 months. This was similar to the trend reported by Vinciguerra et al. [21] and Hersh et al. [22] (Figure 7 ) but in contrast to continued decrease in average K postoperatively as reported by Caporossi et al. [17] and Raiskup-Wolf et al. [18] Confocal microscopy post crosslinking shows a time dependent stratification of the corneal epithelium after three months of the procedure [23] . This corresponds to a smoothening of the surface irregularities as the epithelium remodels/heals. This could explain the worsening of average K values in the initial follow up followed by improvement at the 3 month follow up as shown by our study.
Pachymetry measurements in our study were taken by means Pentacam optical pachymetry. In Group 1 the thinnest pachymetry reduced significantly at 3 months (mean change −53.25 µm, p < 0.001) and 6 months (mean change −45.53 µm, p < 0.001) when compared to baseline. In the older Group, reduction in thinnest pachymetry was lesser in magnitude (mean change −38.72 µm, p < 0.0001; and −31.0 µm, p < 0.0001 at three and six months respectively) but statistically significant. This reduction in thinnest pachymetry can be attributed to measurement artifact as it has been shown that optical pachymetry is affected negatively by the non-homogen- ous optical changes seen in crosslinked corneas (due to corneal haze/demarcation line/stromal edema) [23] [24] . The Siena Study group [17] compared pachymetric results of the optical Obrscan IIz with ultrasound pachymetry and confocal pachymetric examinations and found a significant underestimation (−120 µm in the first six months) of corneal thickness with the Orbscan IIz. Ultrasound and confocal postoperative pachymetric data did not show significant differences with respect to preoperative values. They concluded that confocal data and ultrasound pachymetry seemed to be less influenced by corneal collagen crosslinking induced stromal microstructural changes, providing more reliable postoperative pachymetric measurements. Some of the thinning observed postoperatively may be attributed to stromal "compression/compaction" as a result of increased number of crosslinks between adjacent collagen lamellae in the stroma. In summary, post crosslinking, visual acuity and corneal steepness worsen at the 1 month time point. Resolution to baseline occurs approximately at the 3 month interval, with improvement thereafter. The older group appeared to have benefitted from the procedure, in terms of halt of progression of keratoconus. The mean spherical equivalent of refraction in the younger age group showed a continuous worsening up to the 6 month time point, despite improvement in mean cylindrical error and topography. The question remains that was this increasing 
